Table 5 Predictors of receiving bone mineral density (BMD) measurement and predictors of osteoporosis (OP) treatment: Results from logistic regression models for men
| Â | BMD testing | OP Treatment | ||
|---|---|---|---|---|
Covariates | Crude OR | Adjusted OR (95% CI) | Crude OR | Adjusted OR (95% CI) |
Age in years | Â | Â | Â | Â |
65–69 | 1.00 | - | 1.00 | - |
70–74 | 0.97 | 0.96 (0.69; 1.33) | 1.42 | 1.46 (1.06; 2.01) * |
75–79 | 0.86 | 0.86 (0.61; 1.20) | 1.75 | 1.64 (1.20; 2.25) * |
≥80 | 0.34 | 0.37 (0.25; 0.54) *** | 1.44 | 1.54 (1.14; 2.08)* |
Fracture | Â | Â | Â | Â |
Hip | 1.00 | - | 1.00 | - |
Humerus | 1.40 | 1.09 (0.75; 1.58) | 0.87 | 0.84 (0.60; 1.17) |
Wrist | 1.34 | 1.01 (0.65; 1.57) | 0.50 | 0.57 (0.35; 0.91) * |
Vertebral | 3.53 | 2.77 (2.06; 3.72)*** | 5.49 | 5.15 (4.13; 6.42) *** |
Social status § |  |  |  |  |
At home with no IS | 1.00 | - | 1.00 | - |
At home with partial IS | 0.79 | 0.81 (0.62; 1.06) | 1.33 | 1.27 (1.04; 1.56) * |
At home with max IS | 0.79 | 0.77 (0.40; 1.51) | 1.10 | 1.26 (0.77; 2.07) |
Living in LTCF | 0.05 | 0.08 (0.01; 0.57)* | - | - |
Comorbidity index | 1.03 | 1.00 (0.98; 1.02) | 1.09 | 1.05 (1.04; 1.07)*** |
Prior BMD testing | 9.71 | 5.15 (3.00; 8.85)*** | 15.8 | 3.80 (2.19; 6.58)*** |
Prior OP treatment | 3.45 | 1.36 (0.83; 2.23) | 26.1 | 14.5 (10.4; 20.1)*** |
Long-term glucocorticoid use | 5.16 | 2.95 (1.75; 4.97) | 7.82 | 2.44 (1.54; 3.86) ** |
Distance from BMD device | Â | Â | Â | Â |
≤ 32 km | 1.00 | - | - | - |
Between 32 and 64 km | 1.03 | 0.99 (0.64; 1.52) | Â | Â |
Between 64 and 105 km | 0.61 | 0.65 (0.30; 1.41) | Â | Â |
More than 105 km | 0.14 | 0.14 (0.03; 0.55)* | Â | Â |